Jennifer Fried, CEO of ExplORer Surgical, explains the stress that COVID-19 has placed on healthcare and the shift in how medical device reps are connecting with hospitals and healthcare providers.
Medical device recalls were up more than 31% during Q2 2020, activity that suggests recalls will reach 1200 by the end of the year, according to Stericycle’s latest recall report.
New health-related data is arriving almost daily. Making sense of it all is a huge challenge.
During product development, collaboration between software, hardware and quality teams must be tracked and seamless to meet the increasing pace of market demand.
Companies developing technologies that integrate AI need to consider regulatory concerns, community demographics, fitting into existing workflows, technical proficiency of both the hospital personnel and consumers.
Operating with an antiquated QMS raises your risk. Here’s what to consider when modernizing your system.
The medical device industry is pressured to aid those stricken by the pandemic, while at the same time working to mitigate increased risks usually associated with hurried manufacturing and quality control procedures.
While connected capabilities and wireless technology certainly lead to greater patient care, they also expose devices to greater cybersecurity risks.
With the rapid growth of life tech discoveries, there is a need to adapt the patent and regulatory frameworks governing the approval, use, and protection of such discoveries.
The immense challenges posed by the coronavirus pandemic are fueling interest in cloud computing among vaccine researchers, clinicians, healthcare companies and patients across Asia.